Literature DB >> 9930942

Cytokine mRNA expression in peripheral blood cells of immunosuppressed human islet transplant recipients.

A El-Ouaghlidi1, H Jahr, G Pfeiffer, B J Hering, D Brandhorst, H Brandhorst, K Federlin, R G Bretzel.   

Abstract

The macrophage derived cytokines interleukin-beta (IL-1beta), and tumor necrosis factor alpha (TNFalpha), and the T-cell derived cytokine interferon gamma (IFNgamma) have been implicated to play an important role in early attack on islet cells during human islet transplantation (ITx). Therefore, the aim of this study was to investigate the influence of the current immunosuppressive induction therapy in clinical islet transplantation on mRNA expression of these cytokines in blood cells, compared to lipopolysaccharide (LPS) induced cytokine release in vitro and to plasma levels. The cytokine release correlated to lymphocyte counts and significantly decreased after ATG, and partially recovered 2 weeks after ITx. Unexpectedly, there was no correlation between mRNA expression for IL-1beta in total blood and the number of lymphocytes and monocytes remaining after anti thymocyte globulin (ATG)-therapy. Even when the blood was nearly totally depleted from mononuclear cells, high amounts of IL-1beta mRNA could be detected. However, IL-1beta secretion could not be stimulated in vitro. Our results show that application of ATG during ITx might contribute to graft survival during the early posttransplant period by suppression of the synthesis of monocyte derived cytokines IL-1beta and TNFalpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9930942     DOI: 10.1007/s001090050315

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  5 in total

1.  Islet cell transplantation today.

Authors:  Reinhard G Bretzel; Henning Jahr; Michael Eckhard; Isabel Martin; Daniel Winter; Mathias D Brendel
Journal:  Langenbecks Arch Surg       Date:  2007-03-28       Impact factor: 2.895

Review 2.  Xenotransplantation: Current Status in Preclinical Research.

Authors:  Tianyu Lu; Bochao Yang; Ruolin Wang; Chuan Qin
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

3.  Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research.

Authors:  Hamid Khodayari; Saeed Khodayari; Solmaz Khalighfard; Arash Tahmasebifar; Mahboubeh Tajaldini; Amirhoushang Poorkhani; Hassan Nikoueinejad; Gholam Ali Hamidi; Hassan Nosrati; Mohammad Reza Kalhori; Ali Mohammad Alizadeh
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

Review 4.  Current status of xenotransplantation research and the strategies for preventing xenograft rejection.

Authors:  Qiao Zhou; Ting Li; Kaiwen Wang; Qi Zhang; Zhuowen Geng; Shaoping Deng; Chunming Cheng; Yi Wang
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

5.  Characterisation of the xenogeneic immune response to microencapsulated fetal pig islet-like cell clusters transplanted into immunocompetent C57BL/6 mice.

Authors:  Vijayaganapathy Vaithilingam; Cherry Fung; Sabina Ratnapala; Jayne Foster; Vijesh Vaghjiani; Ursula Manuelpillai; Bernard E Tuch
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.